Dose-escalation, first-in-human Phase I trial showed good safety and tolerability across all dose-cohorts, meeting the primary endpoint Data included observations of immune activation with vaccine ...

Intensive classes in cooking, flower arrangement, and mixology have been booming with young people wanting better Tet parties for the Lunar New Year holiday. At a cooking class in downtown Ho Chi Minh ...

OSLO, Norway--(BUSINESS WIRE)--Ultimovacs ASA ("Ultimovacs", ticker ULTI), today announced the treatment of the first patient in the Phase I TENDU trial, representing the start of clinical evaluation ...

PHILADELPHIA, Sept. 3 ERT (Nasdaq: ERES) has celebrated a significant milestone by completing its 150th thorough QT clinical Trial (TET). ERT provides full TET support to the biopharmaceutical ...